Finished
Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis
NCT06921551 · ABLE Human Motion S.L. · Updated 2 June 2026
- What is being tested
- ABLE Exoskeleton
- For
- Multiple Sclerosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 70 years. About 19 people. The full rules are on the registry page.
- Where
- Spain
- When
- Starts or started 7 April 2025, ends 29 May 2026. Registered 10 April 2025.
- Results
- None posted yet.
In the researchers' words
The goal of this study is to explore the potential clinical benefits of the ABLE Exoskeleton as part of a rehabilitation program in people with multiple sclerosis. The main question it aims to answer is: Can a rehabiliation program with the ABLE Exoskeleton help to mantain the physical and psychosocial health of people with multiple sclerosis? Participants will: * Have a gait training session of 60 min with the exoskeleton once a week for 12 months at the clinic * Have an evaluation (tests and questionnaires) every 3 months at the clinic
Sites
- Fundación Esclerosis Múltiple Madrid (FEMM)Madrid, Madrid, Spain